PACT Act Filing Date Approaching
Esophageal Cancer Patients are among those who may qualify for the expansive benefits of the PACT Act – including more [...]
Sleep Habits Affect Risk of Esophageal Cancer
Study finds Sleep Habits affect Risk of Esophageal Cancer. Researchers at Washington University School of Medicine in St. Louis, [...]
A Father’s Day Reflection
Father's Day is meant to shine a light on the special relationship children have with their fathers. We think that [...]
A Survivor’s Story
Gary Gilbert of York, Pennsylvania was diagnosed with Stage III Esophageal Adenocarcinoma in 2010. This is his story.
Small but Mighty, ECAN turns 12
Twelve years ago, a small but mighty group of dedicated folks who wanted to see significant change for patients [...]
ECAN Experts cited in US News & World Report
"Esophageal Cancer: What to Know" is a new report from U.S. News & World Report by contributing writer David Levine. [...]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies in three new designations for [...]
Hope is Important
These are challenging times. And we at ECAN are keeping our focus trained on the positive difference we can [...]
Immunotherapy Breakthroughs for Esophageal Cancer Patients
The early results of two large, Phase III clinical trials of the immunotherapy Opdivo (nivolumab) showed significant survival benefits for [...]
Barrett’s Esophagus and Esophageal Adenocarcinoma can run in Families
The familial connection is one of the Strongest Indicators of Risk according to Experts. ECAN spoke with the Leading Researcher [...]